PhD, Director, Genomic Immuno-Oncology
Jens holds a PhD in Bioinformatics from the Technical University of Denmark.
He is the former CEO of EIR Sciences (CRO within immunological bioinformatics), and co-founder of VenomAb IVS, a company developing cheaper and safer antivenoms against snake bites.
He is specialized in immunological bioinformatics and chemoinformatics for prediction of polypharmacology. Jens is directing Evaxion’s genomic immuno-oncology program.